14 completed, 1 unknown. 8 Phase 3, 7 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 8 |
| Phase 2 | 7 | Completed 6, Unknown 1 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow Dow Pharmaceutical Sciences: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of IDP-118 in Participants With Plaque Psoriasis IDP-118 Lotion, IDP-118 Vehicle Lotion - Plaque Psoriasis | Phase 3 | Completed | Bausch Health Americas, Inc. | 215 | 2015-08-19 | 2026-10-20 |
| Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis IDP-118 Lotion - Plaque Psoriasis | Phase 3 | Completed | Bausch Health Americas, Inc. | 555 | 2015-08-11 | 2020-01-27 |
| Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis IDP-118 Lotion, IDP-118 Vehicle Lotion - Plaque Psoriasis | Phase 3 | Completed | Bausch Health Americas, Inc. | 203 | 2015-08-11 | 2020-08-20 |
| Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis IDP-118 Lotion, IDP-118 Monad HP Lotion, IDP-118 Monad Taz Lotion - Plaque Psoriasis | Phase 2 | Completed | Bausch Health Americas, Inc. | 212 | 2014-02-01 | 2020-08-20 |
| Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne ACYC, ACYC vehicle - Acne | Phase 3 | Completed | Bausch Health Americas, Inc. | 498 | 2012-10-01 | 2018-06-04 |
| A Phase 2 Dose Ranging, Evaluator-Blinded Study to Evaluate the Safety of Topical IDP-118 IDP-118 Low Strength, IDP-118 High Strength - Plaque Psoriasis | Phase 1 / Phase 2 | Unknown | Dow Pharmaceutical Sciences | 60 | 2012-06-01 | 2013-04-25 |
| A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris Low Strength IDP-107, High Strength IDP-107, Placebo - Acne Vulgaris | Phase 2 | Completed | Dow Pharmaceutical Sciences | 180 | 2010-09-01 | 2012-07-02 |
| The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis IDP-108, Vehicle - Onychomycosis | Phase 3 | Completed | Dow Pharmaceutical Sciences | 780 | 2009-11-01 | 2012-06-22 |
| Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis IDP-108, Vehicle - Onychomycosis | Phase 3 | Completed | Dow Pharmaceutical Sciences | 870 | 2009-11-01 | 2012-06-22 |
| A Study to Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD) KP-413 Ointment - Atopic Dermatitis | Phase 1 / Phase 2 | Completed | Kaken Pharmaceutical | 58 | 2009-07-01 | 2012-04-06 |
| A Clinical Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris Low Strength IDP-107, High Strength IDP-107, Placebo Comparator - Acne Vulgaris | Phase 2 | Completed | Dow Pharmaceutical Sciences | 366 | 2008-01-01 | 2012-02-20 |
| A Clinical Study Evaluating the Safety and Efficacy of IDP-115 in Patients With Rosacea IDP-115, Vehicle - Rosacea | Phase 2 | Completed | Dow Pharmaceutical Sciences | 140 | 2007-11-01 | 2012-02-20 |
| A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-108 in Patients With Onychomycosis Low Strength IDP-108, High Strength IDP-108, High Strength IDP-108 under occlusion - Onychomycosis | Phase 2 | Completed | Dow Pharmaceutical Sciences | 135 | 2007-10-01 | 2012-06-22 |
| A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris IDP-110, Clindamycin, Benzoyl peroxide - Acne Vulgaris | Phase 3 | Completed | Dow Pharmaceutical Sciences | 1414 | 2006-10-01 | 2008-04-22 |
| A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris IDP-110, Clindamycin, Benzoyl peroxide - Acne Vulgaris | Phase 3 | Completed | Dow Pharmaceutical Sciences | 1399 | 2006-10-01 | 2008-04-22 |
Acne Vulgaris (5) · Onychomycosis (3) · Dermatitis, Atopic (1) · Psoriasis (1) · Rosacea (1)
Benzoyl Peroxide (2) · Clindamycin (2) · Transcriptional Coactivator with PDZ-Binding Motif Proteins (1)
United States (14) · Canada (4) · Belize (1) · Japan (1) · Mexico (1)
Binu J Alexander (3) · Barry Calvarese, MS (1) · Binu J Alexander, MD (1) · Nilima Justice, M.D. (1) · Todd Plott, MD (1)